PMID: 9271620

Kerem E, Nissim-Rafinia M, Argaman Z, Augarten A, Bentur L, Klar A, Yahav Y, Szeinberg A, Hiba O, Branski D, Corey M, Kerem B
A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype.
Pediatrics. 1997 Sep;100(3):E5., [PubMed]
Sentences
No. Mutations Sentence Comment
20 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:20:10
status: NEW
view ABCC7 p.Gly85Glu details
Thus, the G85E mutation cannot be classified either as a severe or as a mild mutation. Login to comment
33 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:33:106
status: NEW
view ABCC7 p.Gly85Glu details
Pancreatic status was suggested to be the best parameter in differentiating between the two groups.17 The G85E mutation is a missense mutation result- From the *Department of Pediatrics, Cystic Fibrosis (CF) Clinic, Shaare Zedek Medical Center, Jerusalem, Israel; and the ‡Department of Genetics, Hebrew University, Jerusalem; the §Department of Paediatrics, CF Clinic, Chaim Sheba Medical Center, Tel Hashomer, Israel; the ʈDepartment of Paediatrics, CF Clinic, Rambam Medical Center, Haifa; the ¶Department of Paediatrics, Bikur Cholim Hospital, Jerusalem, Israel; and the #Research Institute, Hospital for Sick Children, Toronto, Canada. Login to comment
39 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:39:46
status: NEW
view ABCC7 p.Gly85Glu details
3 September 1997 ing from a substitution of glutamic acid for glycine at amino acid 85. Login to comment
42 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:42:177
status: NEW
view ABCC7 p.Gly85Glu details
Two patients, 1 with PI and the other with PS and exceptionally mild lung disease, were previously reported.18,19 Thus, for further determination of the correlation between the G85E mutation and disease phenotype a larger cohort of patients was required. Login to comment
63 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:63:192
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:63:298
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:63:359
status: NEW
view ABCC7 p.Gly85Glu details
Hybridization to RT-PCR Products 50 ␮L of each differential RT-PCR reaction were subjected to electrophoresis and were subsequently blotted and hybridized to the exon 3 oligonucleotide G85E-N 5ЈGTTCTATGGAATCTTT 3Ј that identified the normal sequence, washed at 42°C, and to G85E-M 5ЈGTTCTATGAAATCTTT 3Ј that identified the G85E mutation, washed at 40°C. Login to comment
70 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:70:76
status: NEW
view ABCC7 p.Gly85Glu details
To assess the severity of disease presentation of the patients carrying the G85E mutation, we compared their clinical parameters with those of two groups of patients. Login to comment
71 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:71:83
status: NEW
view ABCC7 p.Trp1282* details
The first was comprised of 40 patients homozygous or compound heterozygous for the W1282X and ⌬F508 mutations, both associated with severe disease presentation.2,3 In the second group were 20 patients carrying the 3849ϩ10kb C-ϾT mutation, which is associated with higher frequency of PS and a milder phenotype.7,8 Statistical Analysis Mean values of continuous variables were compared using analysis of variance and Student`s t test. Login to comment
75 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:75:51
status: NEW
view ABCC7 p.Gly85Glu details
RESULTS Twelve CF patients were found to carry the G85E mutation, 9 were Arab, 8 from the same extended family (Table 1, patients 1 to 4 and 6 to 9), and 3 were Jews from Turkish origin (patients 10 to 12). Login to comment
76 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:76:119
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:76:37
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:76:92
status: NEW
view ABCC7 p.Gly85Glu details
Six patients were homozygous for the G85E mutation and 6 were compound heterozygote for the G85E and the ⌬F508, W1282X or the 3849ϩ10kb C-ϾT mutations. Login to comment
77 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:77:41
status: NEW
view ABCC7 p.Gly85Glu details
All the studied chromosomes carrying the G85E mutation had the 7T variant in the polythymidine tract at the branch/acceptor site in intron 8. Login to comment
78 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:78:53
status: NEW
view ABCC7 p.Gly85Glu details
The clinical parameters of the patients carrying the G85E mutation are presented in Table 1. Login to comment
79 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:79:80
status: NEW
view ABCC7 p.Gly85Glu details
It shows a high variability in the age at diagnosis among patients carrying the G85E. Login to comment
85 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:85:38
status: NEW
view ABCC7 p.Gly85Glu details
One had 3 children homozygous for the G85E mutation (Table 1, patients 1 to 3). Login to comment
89 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:89:59
status: NEW
view ABCC7 p.Gly85Glu details
The second family had 2 children compound heterozygous for G85E and ⌬F508 mutations (Table 1, patients 7 and 8). Login to comment
92 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:92:101
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:92:40
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:92:425
status: NEW
view ABCC7 p.Gly85Glu details
Comparison of the patients carrying the G85E mutation with patients carrying the ⌬F508 and/or W1282X mutations previously associated with PI and the more severe disease (group 1) or with patients carrying the 3849ϩ10kb C-ϾT previously associated with higher frequency of PS and a milder disease (group 2), revealed that the mean age at diagnosis and age at assessment in the group of patients carrying the G85E mutation were not significantly different from those in group 1, but significantly lower than in group 2 (P ϭ .001 for age of diagnosis, P ϭ .04 for age at assessment; Table 2). Login to comment
93 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:93:62
status: NEW
view ABCC7 p.Gly85Glu details
Likewise, mean sweat chloride levels in patients carrying the G85E mutation was similar to group 1, and significantly higher than group 2 (P ϭ .001; Table 2). Login to comment
94 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:94:131
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:94:42
status: NEW
view ABCC7 p.Gly85Glu details
Thus, it seems that patients carrying the G85E mutation have similarly severe disease as patients carrying the ⌬F508 and/or W1282X mutations. Login to comment
95 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:95:170
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:95:261
status: NEW
view ABCC7 p.Gly85Glu details
However, the F test of equal variance was significantly different between these groups: the range of age at diagnosis and sweat chloride levels were much broader for the G85E group than for group 1 (P Ͻ .0001), and sweat chloride was more variable in the G85E mutation than in group 2 (P ϭ .002). Login to comment
97 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:97:42
status: NEW
view ABCC7 p.Gly85Glu details
Clinical Data of CF Patients Carrying the G85E Mutation Patient No. Login to comment
98 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:98:827
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:98:887
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:155
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:160
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:232
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:237
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:301
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:306
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:362
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:367
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:440
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:445
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:513
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:518
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:602
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:665
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:726
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:822
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:882
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:98:962
status: NEW
view ABCC7 p.Gly85Glu details
Genotype Sex Age at Diagnosis Sweat Chloride meq/l Mode of Presentation Current Age Pancreatic Status FEV1 % Predicted Weight Percentile Sputum Culture 1* G85E/G85E F 9 mo 143 Respir ϩ GI Died 13 y PI NA Ͻ3 Klebsiela 2* G85E/G85E M 2 mo 184 Respir Died 10 y PI NA Ͻ3 H influenzae 3* G85E/G85E M 12 y 54 Liver 13 y PS 82 Ͻ3 H influenzae 4 G85E/G85E F 6 mo 157 Respir ϩ GI Died 6 y PI 20 Ͻ3 P aeruginosa 5 G85E/G85E F 2 mo 90 Respir ϩ GI 4 mo PI NA Ͻ3 H influenzae 6 G85E/G85E F 3 mo 97 Respir ϩ GI 6 yr PS 86 35 H influenzae ϩ Staph 7† G85E/⌬F508 M 6 mo 158 GI Died 11 y PI NA 3 NA 8† G85E/⌬F508 M 10 y 108 Screening 12 y PS 83 80 Staph 9 G85E/⌬F508 M 5 mo NA Respir ϩ GI 18 y PI 50 Ͻ3 P aeruginosa ϩ Staph 10 G85E/W1282X F 7 mo 117 Respir 20 y PI 65 50 P aeruginosa 11 G85E/W1282X F 19 y 82 Pancreatitis ϩ Respir 34 y PI 22 50 P aeruginosa 12 G85E/3849 ϩ 10KB M 5 mo 54 Respir 10 y PI 65 97 P aeruginosa * and † Patients are siblings, respectively. Login to comment
101 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:101:151
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:101:253
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:101:260
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:101:293
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:101:61
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:101:248
status: NEW
view ABCC7 p.Gly85Glu details
Comparison of Clinical Data Between CF Patients Carrying the G85E Mutations and Patients Homozygous or Compound Heterozygous for Two Severe Mutations (W1282X and ⌬F508) and Those Carry a Milder Mutation (3849ϩ10kb C-ϾT) Variable G85E W1282X/W1282X ⌬F508/⌬F508 W1282X/⌬F508 3849 ϩ 10kb C-ϾT n 12 40 21 Age at diagnosis* 3.7 Ϯ 6.3 0.7 Ϯ 1.8࿣ 13.2 Ϯ 7.8 Sweat chloride (mmol/L)* 119 Ϯ 38 111 Ϯ 12࿣ 71 Ϯ 18¶ Died, n 4 2 2 Pancreatic sufficiency, %§ 25 0 79 Meconium ileus, %§ 0 33 0 Current age, y† 12.8 Ϯ 8.5 10.8 Ϯ 7.0 19.8 Ϯ 8.8 Weight (percentile)‡ 28 Ϯ 34 24 Ϯ 24 50 Ϯ 34 Forced expiratory volume in 1 second (% predicted) 55 Ϯ 26 (n ϭ 7) 66 Ϯ 28 (n ϭ 24) 55 Ϯ 21 (n ϭ 19) * P Ͻ .0001, † P Ͻ .001, ‡ P Ͻ .01 analysis of variance for three means. Login to comment
103 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:103:63
status: NEW
view ABCC7 p.Gly85Glu details
࿣ P Ͻ .0001 F test of equal variance compared with G85E. Login to comment
104 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:104:60
status: NEW
view ABCC7 p.Gly85Glu details
¶ P Ͻ .01 F test of equal variance compared with G85E. Login to comment
105 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:105:29
status: NEW
view ABCC7 p.Gly85Glu details
Of the patients carrying the G85E mutation, 25% had PS significantly higher than in group 1 (0%), and significantly lower than in group 2 (80%) (P Ͻ .001; Table 2). Login to comment
106 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:106:83
status: NEW
view ABCC7 p.Gly85Glu details
Furthermore, similar to the patients in group 2, none of the patients carrying the G85E mutation had meconium ileus, whereas a third of the patients from group 1 had meconium ileus (P ϭ .002). Login to comment
107 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:107:48
status: NEW
view ABCC7 p.Gly85Glu details
The nutritional status of patients carrying the G85E mutation was poor. Login to comment
109 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:109:42
status: NEW
view ABCC7 p.Gly85Glu details
However, 58% of the patients carrying the G85E mutation were under the third percentile of weight, compared with 25% of the group 1 patients (P ϭ .02), and 20% of group 2 (0.05). Login to comment
114 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:114:58
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:114:209
status: NEW
view ABCC7 p.Gly85Glu details
Levels of Correctly Spliced CFTR RNA Transcribed From the G85E Allele in Respiratory Epithelium We next studied the possibility that the variability in pulmonary function found among our patients carrying the G85E mutation is associated with the level of exon 9 skipping that leads to the translation of a nonfunctional CFTR protein. Login to comment
115 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:115:94
status: NEW
view ABCC7 p.Gly85Glu details
The level of aberrantly spliced CFTR RNA transcribed in respiratory epithelial cells from the G85E allele was analyzed using semiquantitative nondifferential RT-PCR. Login to comment
116 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:116:98
status: NEW
view ABCC7 p.Gly85Glu details
The RT-PCR was performed on respiratory epithelial cells from 3 patients who carried at least one G85E allele (patients 3, 8, and 9). Login to comment
118 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:118:85
status: NEW
view ABCC7 p.Gly85Glu details
The results showed that the level of transcripts lacking exon 9 transcribed from the G85E allele was 55 Ϯ 3% for patient 3, 49 Ϯ 2% for patient 8, and 35 Ϯ 4% for patient 9. Login to comment
121 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:121:128
status: NEW
view ABCC7 p.Gly85Glu details
Thus, the level of aberrantly spliced transcripts could not explain the variable pulmonary function among patients carrying the G85E mutation. Login to comment
122 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:122:105
status: NEW
view ABCC7 p.Gly85Glu details
DISCUSSION This study demonstrates high variability of clinical presentation among patients carrying the G85E mutation. Login to comment
123 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:123:10
status: NEW
view ABCC7 p.Gly85Glu details
Thus, the G85E mutation cannot be classified either as a severe or as a mild mutation. Login to comment
126 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:126:147
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9271620:126:166
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9271620:126:158
status: NEW
view ABCC7 p.Gly542* details
Several genotype-phenotype studies including the CF genotype-phenotype consortium have shown that there are mutations like the ⌬F508,2,6,11 W1282X,3,6 G542X,6 N1303K,4,6 and R533X5,6 in which Ͼ95% of the patients had PI2-10 whereas others like the 3849ϩ10kb C-ϾT,7,8 A455E15 Fig 1. Login to comment
129 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:129:35
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:129:42
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9271620:129:63
status: NEW
view ABCC7 p.Trp1282* details
Severe: ⌬F508/⌬F508, W1282X/W1282X, ⌬F508/W1282X. Login to comment
131 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:131:52
status: NEW
view ABCC7 p.Gly85Glu details
The incidence of PS among the patients carrying the G85E mutation (25%), suggests that it cannot be classified either as a PI- or PS-associated mutation. Login to comment
132 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:132:244
status: NEW
view ABCC7 p.Gly85Glu details
Slightly elevated, borderline, or even normal values of sweat chloride were previously reported among patients carrying at least one copy of the splicing mutation 3849ϩ10kb C-ϾT.7,8,15 Two of the patients in our study, carrying the G85E mutation, had borderline sweat chloride levels, whereas the others had typically high levels. Login to comment
133 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:133:52
status: NEW
view ABCC7 p.Gly85Glu details
Furthermore, as shown in Table 2, it seems that the G85E patients present to medical attention at a later age than the patients in the severe group. Login to comment
134 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:134:88
status: NEW
view ABCC7 p.Gly85Glu details
However, again this is attributable to the wide range of the age of diagnosis among the G85E patients, and not attributable to a milder disease course. Login to comment
136 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:136:48
status: NEW
view ABCC7 p.Gly85Glu details
Thus, the results of our analysis show that the G85E mutation is associated with variable disease presentation in all the studied parameters. Login to comment
139 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:139:75
status: NEW
view ABCC7 p.Gly85Glu details
The mechanism causing the variability seen among the patients carrying the G85E mutation is unknown. Login to comment
141 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:141:201
status: NEW
view ABCC7 p.Gly85Glu details
Sequence variations within the CFTR gene that modulate the CF phenotype have been reported in 2 CF patients.29,30 However, in our study 8 patients were from the same extended family, carrying the same G85E allele, as evidenced by extended haplotype analysis using polymorphic markers in the CFTR locus (data not shown). Login to comment
146 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9271620:146:265
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9271620:146:299
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9271620:146:416
status: NEW
view ABCC7 p.Arg117His details
The 5T allele is associated with the lowest levels of normal splicing of exon 9, and high levels of exon 9 skipping leading to a nonfunctional chloride channel.32 Furthermore, the 5T allele was shown to affect the disease severity of patients carrying the mutation R117H.33 In patients carrying the R117H mutation when the allele also contained the 5T variant the phenotype was mild CF, whereas in patients carrying R117H together with the 7T variant the phenotype was male infertility only. Login to comment
147 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:147:21
status: NEW
view ABCC7 p.Gly85Glu details
In our study all the G85E chromosomes contained the 7T variant. Login to comment
148 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:148:79
status: NEW
view ABCC7 p.Gly85Glu details
In addition, the level of RNA transcripts lacking exon 9, transcribed from the G85E allele, varied among different individuals. Login to comment
153 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9271620:153:106
status: NEW
view ABCC7 p.Gly85Glu details
Further understanding the mechanisms underlying the disease variability found among patients carrying the G85E mutation will contribute to our understanding of the genotype-phenotype association and disease variability in CF. Login to comment